• LAST PRICE
    17.0700
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (0.4709%)
  • Bid / Lots
    16.2900/ 1
  • Ask / Lots
    17.9100/ 1
  • Open / Previous Close
    17.1000 / 16.9900
  • Day Range
    Low 16.7900
    High 17.3450
  • 52 Week Range
    Low 10.3800
    High 21.1400
  • Volume
    270,677
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 16.99
TimeVolumeTYRA
09:32 ET2032717.1
09:39 ET120017.345
09:41 ET10017.2
09:43 ET10017.2
09:48 ET30017.22
09:50 ET10017.155
09:52 ET10017.01
09:54 ET10016.89
10:12 ET10016.85
10:15 ET20016.87
10:21 ET20017
10:37 ET10017.04
10:51 ET10017.17
11:04 ET10017.2
11:24 ET40017.21
11:26 ET42017.07
11:36 ET90016.9
11:38 ET108316.9
11:42 ET10016.98
11:58 ET30016.92
12:02 ET20016.81
12:03 ET39416.88
12:18 ET20016.79
12:20 ET10016.85
12:34 ET39716.8
12:36 ET46516.8
12:52 ET50016.83
01:10 ET10016.91
01:30 ET20016.85
01:57 ET20016.93
02:00 ET50016.95
02:02 ET10016.96
02:04 ET30016.94
02:18 ET30016.99
02:24 ET549417.085
02:26 ET220017.055
02:27 ET40017.04
02:29 ET30017.03
02:36 ET70116.995
02:49 ET10016.935
02:54 ET20016.98
02:58 ET10016.99
03:00 ET40016.96
03:05 ET10017
03:14 ET20017
03:18 ET20017
03:21 ET327116.94
03:23 ET20016.95
03:30 ET60016.99
03:34 ET60016.96
03:36 ET70016.96
03:38 ET370016.81
03:39 ET172816.86
03:43 ET30016.89
03:45 ET200716.92
03:48 ET711417.01
03:50 ET240016.989
03:52 ET612417.17
03:54 ET277417.24
03:56 ET337017.12
03:57 ET632517.01
03:59 ET1175617.07
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTYRA
Tyra Biosciences Inc
896.9M
-10.1x
---
United StatesCOGT
Cogent Biosciences Inc
840.4M
-3.6x
---
United StatesETNB
89Bio Inc
838.2M
-4.2x
---
United StatesSAVA
Cassava Sciences Inc
960.5M
-17.1x
---
United StatesLBPH
Longboard Pharmaceuticals Inc
809.1M
-9.2x
---
United StatesRAPP
Rapport Therapeutics Inc
807.2M
-15.2x
---
As of 2024-06-22

Company Information

Tyra Biosciences, Inc. is a clinical-stage biotechnology company. It is focused on developing precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. Its in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations to cause acquired resistance to existing therapies. Its initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. Its lead product candidate, TYRA-300, is an investigational, oral, FGFR3-selective inhibitor being evaluated in an international, multi-center, open label Phase 1 clinical study, SURF301. Its second oncology product candidate, TYRA-200, is an investigational, oral, FGFR1/2/3 inhibitor with potency against activating FGFR2 gene alterations, and clinically important molecular brake and gatekeeper resistance mutations.

Contact Information

Headquarters
2656 State StreetCARLSBAD, CA, United States 92008
Phone
619-728-4760
Fax
302-655-5049

Executives

Non-Executive Chairman of the Board
Robert More
President, Chief Executive Officer, Treasurer, Director
Todd Harris
Chief Financial Officer
Alan Fuhrman
Chief Operating Officer
Daniel Bensen
Chief Medical Officer
Hiroomi Tada

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$896.9M
Revenue (TTM)
$0.00
Shares Outstanding
52.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.68
Book Value
$4.75
P/E Ratio
-10.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.